| Muscular Dystrophy |
1 |
1 |
| Genomic Medicine |
0 |
0.8 |
| Biologic Therapy |
0 |
0.73 |
| Gene Therapy |
0 |
0.98 |
| Child |
0 |
0.99 |
| Aminotransferase |
0 |
0.31 |
| Dystrophinopathies |
0 |
0.29 |
| Liver |
0 |
0.29 |
| Muscle |
0 |
0.22 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.16 |
| Fever |
0 |
0.15 |
| Injury |
0 |
0.15 |
| Wound Management |
0 |
0.15 |
| Blood Chemistry |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| California |
0 |
0.07 |
| Cardiomyopathy |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Intravenous |
0 |
0.07 |
| Myocarditis |
0 |
0.07 |
| Myositis |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Ohio |
0 |
0.07 |
| Shock |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |
| Socioeconomics |
0 |
0.07 |
| Steroids |
0 |
0.07 |
| Thrombocytopenia |
0 |
0.07 |
| Wasting |
0 |
0.07 |